GE HealthCare Technologies (GEHC) Other Non-Current Assets (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Other Non-Current Assets came in at $2.3 billion in Q2 2026, up 8.57% YoY from $2.1 billion in Q2 2025, and little changed on a QoQ basis from $2.3 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Other Non-Current Assets (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Other Non-Current Assets data on file, last reported at $2.3 billion in Q2 2026.
- Quarterly Other Non-Current Assets rose 8.57% year-over-year to $2.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.3 billion (up 8.57% YoY) and the FY2025 annual result came in at $2.2 billion, up 13.08% from the prior year.
- Other Non-Current Assets was little changed at $2.3 billion in Q2 2026, from $2.3 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.3 billion in Q1 2026 to a low of $1.0 billion in Q4 2022.
- A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 83.69% — and 2024, when it retreated 4.97%.
- Tracing GEHC's Other Non-Current Assets over 5 years: stood at $1.0 billion in 2022, then surged by 83.69% to $1.9 billion in 2023, then rose by 3.67% to $2.0 billion in 2024, then grew by 13.08% to $2.2 billion in 2025, then gained by 2.22% to $2.3 billion in 2026.
- The last three Other Non-Current Assets figures came in at $2.3 billion (Q2 2026), $2.3 billion (Q1 2026), and $2.2 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Bn |
| Mar 31, 2026 | 2.25 Bn |
| Dec 31, 2025 | 2.21 Bn |
| Sep 30, 2025 | 2.15 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 1.93 Bn |
| Dec 31, 2024 | 1.95 Bn |
| Sep 30, 2024 | 2.10 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 1.88 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Sep 30, 2023 | 2.04 Bn |
| Jun 30, 2023 | 2.01 Bn |
| Mar 31, 2023 | 1.95 Bn |
| Dec 31, 2022 | 1.02 Bn |